Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide in Advanced HCC
NCT01545804Phase 2Completed
- Sponsor
- National Taiwan University Hospital
- Start
- Aug 2011
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in hepatocellular carcinoma (HCC), sponsored by National Taiwan University Hospital. Started Aug 2011; status: completed.
02
Drugs
lenalidomide
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT01545804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01545804.